48
Participants
Start Date
March 27, 2019
Primary Completion Date
April 8, 2020
Study Completion Date
August 26, 2020
ABBV-3373
ABBV-3373 is administered as intravenous (IV) infusion
Placebo for ABBV-3373
Placebo for ABBV-3373 is administered as IV infusion
Adalimumab
Adalimumab is administered as subcutaneous (SC) injection
Placebo for adalimumab
Placebo for adalimumab is administered as subcutaneous (SC) injection
Budai Irgalmasrendi Korhaz /ID# 208877, Budapest
CRU Hungary Egeszsegugyi és Szolgaltato Kft. /ID# 210055, Miskolc
Debreceni Egyetem Klinikai Kozpont /ID# 210164, Debrecen
DRC Gyogyszervizsgalo Kozpont Kft. /ID# 210159, Balatonfüred
Charite Research Organisation GmbH /ID# 210216, Berlin
Duke Early Phase Research Unit (DCRI) /ID# 213212, Durham
W. Broward Rheum Assoc Inc. /ID# 211017, Tamarac
Suncoast Clinical Research /ID# 213973, New Port Richey
Arthritis Center, Inc. /ID# 213972, Palm Harbor
Rheum Assoc of North Alabama /ID# 213626, Huntsville
West Tennessee Research Inst /ID# 208838, Jackson
Paramount Medical Research Con /ID# 209042, Middleburg Heights
PRN Professional Research Network of Kansas, LLC /ID# 213046, Wichita
PCCR Solution /ID# 215457, Colleyville
Institute of Arthritis Researc /ID# 213043, Idaho Falls
AZ Arthritis and Rheum Researc /ID# 208515, Phoenix
Inland Rheum & Osteo Med Grp /ID# 213044, Upland
C.V. Mehta MD, Med Corporation /ID# 213068, Hemet
Robin K. Dore MD, Inc /ID# 213045, Tustin
Rambam Health Care Campus /ID# 212747, Haifa
Sheba Medical Center /ID# 211339, Ramat Gan
BayCare Medical Group, Inc. /ID# 213935, Tampa
Clinvest Research LLC /ID# 215451, Springfield
STAT Research, Inc. /ID# 213933, Vandalia
Trinity Universal Research Association /ID# 209167, Plano
Academisch Medical center Amsterdam /ID# 209303, Amsterdam
SANUS Szpital Specjalistyczny /ID# 209022, Stalowa Wola
Reumatika - Centrum Reumatologii NZOZ /ID# 209220, Warsaw
GCM Medical Group, PSC /ID# 208154, San Juan
Mindful Medical Research /ID# 208403, San Juan
Lead Sponsor
AbbVie
INDUSTRY